Impact of migraine on patients and their families: the Migraine And Zolmitriptan Evaluation (MAZE) survey – Phase III
Authors:
- 27 April 2004
- journal article
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 20 (7) , 1143-1150
Abstract
SUMMARYObjective: To investigate the impact of migraine on migraineurs and their families and evaluate migraineurs’ preference for different treatment formulations. This study also assessed the prevalence and impact of migraine with menstruation.Methods: Participants (n = 1028) from around the world (USA [39%], Canada [20%], Europe [37%] and other countries [4%]) completed an online questionnaire. Of these, 866 were migraineurs and 162 were non-migraineurs living with/related to migraineurs. Migraineurs were identified based on responses to a modified Kiel questionnaire and/or diagnosis of migraine by a doctor. Disability was quantified using the Migraine Disability Assessment Scale (MIDAS).Results: Migraineurs missed more days from family/leisure activities than from work/school (mean 4.2 vs 2.4 days) in the previous 3 months. On an additional 6.2 days within the 3-month period, productivity at work/school was reduced by at least half. Inability and reduced ability (by at least half) to perform household...Keywords
This publication has 6 references indexed in Scilit:
- Epidemiology of headacheCephalalgia, 2001
- The impact of migraine on quality of life in the general populationNeurology, 2000
- The UK Migraine Patient Survey: Quality of Life and TreatmentCurrent Medical Research and Opinion, 1999
- Risk Factors for Headache Recurrence After Sumatriptan: A Study in 366 Migraine PatientsCephalalgia, 1996
- Paper‐Pencil Tests for Retrospective and Prospective Evaluation of Primary Headaches on the Basis of the IHS CriteriaHeadache: The Journal of Head and Face Pain, 1994
- Migraine and Menstruation: A Pilot StudyCephalalgia, 1990